HomeTagsSGX

SGX

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

Noel Gifts Slashes Losses By 95% While Core Business Retreats In 1H FY2026

The Art of the Narrow Escape In the high-stakes theater of corporate gifting, sentiment is...
SGX-LISTED COMPANIES

iX Biopharma’s Secret Shortcut To The US Medical Market – 1H FY2026

From Cash Burn to Bioavailability: How iX Biopharma Slashed Losses by 67% via a...
SGX-LISTED COMPANIES

Elite UK REIT Secured A Massive Government Payday In FY2025

Sovereign Shields and Strategic Pivots: Why Elite UK REIT’s 5.6% DPU Growth is a...
SGX-LISTED COMPANIES

DBS Record Profit Masks Q4 2025 Rate Squeeze

The $8 Billion Dividend Paradox: What DBS’s 2025 Results Reveal About the Future of...
SGX-LISTED COMPANIES

From Food Processing To Japanese Real Estate – Yamada Green Resources Q2 FY2026

Introduction: When a regional property market cools, standard portfolios often face terminal stagnation. However,...
SGX-LISTED COMPANIES

EuroSports Global Bets Big On Electric Bikes In Q3 FY2026

Introduction: The Luxury Paradox In an era defined by Singapore’s aggressive 2023 luxury vehicle tax...
SGX-LISTED COMPANIES

Hafary Holdings FY2025 US Pivot & Inventory Gamble

From Local Showrooms to Global Strength: 5 Surprising Lessons from Hafary’s Record FY2025 The "Renovation...
SGX-LISTED COMPANIES

Chuan Hup’s $15M Australian Windfall In 1H FY2026

Harvesting the Outback In a market defined by persistent volatility and shifting geopolitical tides, investors...
SGX-LISTED COMPANIES

Can GRP Ltd’s 1H FY2026 AI Pivot Outrun Its Legacy Hurdles?

Navigating the "Messy Middle" of Corporate Transformation How does a traditional industrial player, long associated...
SGX-LISTED COMPANIES

Why British & Malayan Holdings HY2025 Loss Masks A High-Growth Pivot

The Strategic Deficit In corporate finance, a net loss is usually a red flag—a signal...
SGX-LISTED COMPANIES

Asian Micro Sold Assets To Wipe Out 1H FY2026 Losses

Is Asian Micro’s Massive Share Dilution a Lifeline or a Warning? Why Small Moves Matter In...
SGX-LISTED COMPANIES

What’s Driving CapitaLand Integrated Commercial Trust’s Record FY2025 Growth?

The Strategic Pivot In the world of institutional investing, size is often viewed as a...
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...